Online pharma platform to launch delivery service, BNPL option 


UNAPHARMA, a digital medicine reservation platform, will launch its delivery service and a buy now, pay later (BNPL) option in January 2023.  

“The BNPL option will allow customers to purchase medicine with less worry, allowing them to focus on getting better instead of the cost of the medicines themselves,” said Alexander Goriainov, chief executive officer of Una Marketplace, Inc., in a Dec. 9 e-mail.  

A hotline with registered pharmacists and a prescription refill service are also in the pipeline for the first quarter of next year.  

UnaPharma, which allows customers to compare drug prices, has 400 pharmacies on its platform. It requires its members to have a license to operate from the Food and Drug Administration.   

“Some of them, for now, are just exploring its digital services; we conduct training sessions for them so they could start adding their medicines and processing orders,” said Mr. Goriainov, who founded UnaPharma after he had to visit more than five pharmacies to find the eye drops that were prescribed to him for an eye infection. 

Statista values the Philippine digital health market at $684 million, with 12.7% growth potential for 2022–2027.  

Robocash Group, a Singapore-headquartered fintech holding company, is UnaPharma’s only investor. — Patricia B. Mirasol 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Your daily news source covering investing ideas, market stocks, business, retirement tips from Wall St. to Silicon Valley.

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 TheProficientInvestor. All Rights Reserved.

To Top